Edgewise Therapeutics Q2 EPS $(0.53) Misses $(0.47) Estimate
Benzinga Newsdesk 3 months ago
NewsEarningsEarnings Misses
Edgewise Therapeutics (NASDAQ:EWTX) reported quarterly losses of $(0.53) per share which missed the analyst consensus estimate of $(0.47) by 12.77 percent. This is a 55.88 percent decrease over losses of $(0.34) per
Edgewise Therapeutics (NASDAQ:EWTX) reported quarterly losses of $(0.53) per share which missed the analyst consensus estimate of $(0.47) by 12.77 percent. This is a 55.88 percent decrease over losses of $(0.34) per share from the same period last year.